Bill
Bill > HB1244
MD HB1244
MD HB1244Health Insurance – Lyme Disease and Related Tick–Borne Illnesses – Long–Term Antibiotic Treatment
summary
Introduced
02/11/2022
02/11/2022
In Committee
02/11/2022
02/11/2022
Crossed Over
Passed
Dead
04/11/2022
04/11/2022
Introduced Session
2022 Regular Session
Bill Summary
Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for the full length of long-term antibiotic treatment of Lyme disease and related tick-borne illnesses under certain circumstances; and prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from placing a quantitative limit on or denying coverage for benefits required under the Act.
AI Summary
This bill requires certain insurers, nonprofit health service plans, and health maintenance organizations in Maryland to provide coverage for the full length of long-term antibiotic treatment of Lyme disease and related tick-borne illnesses when prescribed by a licensed physician for therapeutic purposes. It prohibits these entities from placing quantitative limits on or denying coverage for such treatments, even if they are considered unproven, experimental, or investigational. The bill applies to all policies, contracts, and health benefit plans issued, delivered, or renewed in the state on or after January 1, 2023, and takes effect on that date.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
House Health and Government Operations Hearing (13:30 3/3/2022 ) (on 03/03/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1244?ys=2022RS |
| BillText | https://mgaleg.maryland.gov/2022RS/bills/hb/hb1244f.pdf |
Loading...